Larreacorp

LarreaCorp is a biotechnology company focused on the research, development, and commercialization of therapeutic compounds derived from the Larrea tridentata (creosote bush) plant. The company specializes in the extraction and stabilization of Nordihydroguaiaretic acid (NDGA) and its derivatives, which exhibit potent antioxidant, antiviral, and anti-inflammatory properties. LarreaCorp operates primarily through its LarreaRx brand, offering a range of botanical treatments for viral conditions such as Herpes Simplex and Human Papillomavirus (HPV). Beyond its commercial nutraceutical line, the company investigates clinical-grade applications of Larrea-based lignans for chronic inflammatory diseases and oncology.